THROMBOLOGIC ApS: Financial statements 2012

CVR: 32299814

THROMBOLOGIC ApS (CVR 32299814) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -2,904,980 and a net result of DKK -2,792,212. Equity amounted to DKK -1,331,545.

Gross Profit: -2,904,980 kr.
Profit/Loss: -2,792,212 kr.
Equity: -1,331,545 kr.
Total Assets: 4,237,007 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is THROMBOLOGIC ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2012

THROMBOLOGIC ApS appoints new auditorNov 20, 2012

As of November 20, 2012, EY Danmark A/S has been appointed auditor of THROMBOLOGIC ApS.

Auditor steps down at THROMBOLOGIC ApSNov 20, 2012

As of November 20, 2012, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of THROMBOLOGIC ApS.

THROMBOLOGIC ApS appoints new auditorJan 1, 2012

As of January 1, 2012, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of THROMBOLOGIC ApS.

Auditor steps down at THROMBOLOGIC ApSJan 1, 2012

As of January 1, 2012, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has stepped down as auditor of THROMBOLOGIC ApS.

About THROMBOLOGIC ApS

THROMBOLOGIC ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2009 and dissolved in 2014. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees. In 2012, the company reported a gross profit of DKK -2,904,980 and a net result of DKK -2,792,212. Equity amounted to DKK -1,331,545.